ebsi.com — September 2026 traffic, keywords & AI visibility

Paid search ads bring 100% of it — more than its organic results do.

On our AI visibility scale ebsi.com earns 67 of 100 points, a grade C. It takes full marks for LLMS.txt and Structured data. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10) and Company profile (22/25).

The llms.txt on ebsi.com runs to 168 lines (7,867 characters) across 12 sections, last generated in May 2026. It introduces the site as "Emergent BioSolutions U.S. - Global Specialty Life Sciences Company". It tells AI engines the business works in Biotechnology, Biodefense, Vaccine Manufacturing and Medical Countermeasures. It describes 5 products, including BioThrax (Anthrax Vaccine Adsorbed), CYFENDUS and ACAM2000. Services it lists include Drug Substance Manufacturing, Drug Product Manufacturing, Process & Product Development and BioStorage Services. The audience it names is Government Agencies, Military, Public Health Organizations (Global with U.S. focus). Technologies it mentions include HTTPS, Responsive Viewport and Corporate CMS. The keywords it claims start with "biodefense", "vaccines", "anthrax vaccine" and "smallpox vaccine". It gives the company type as Public and says it is hiring.

# Emergent BioSolutions U.S. - Global Specialty Life Sciences Company

## About
Emergent BioSolutions leads the charge in specialty life sciences, delivering vaccines and therapeutics that tackle bioterrorism and pandemic threats head-on. They serve civilian and military sectors with products like BioThrax for anthrax protection and ACAM2000 against smallpox, ensuring rapid deployment when crises hit. Their manufacturing muscle supports government stockpiles and emergency responses worldwide. From contract development to fill-finish services, they enable partners to scale biopharma solutions fast. With deep ties to U.S. agencies like BARDA, they've proven essential in national security and public health defense. Their facilities crank out high-quality countermeasures under strict FDA guidelines. Emergent also handles plasma-derived treatments for rare conditions tied to biothreats. In COVID times, they pivoted to vaccine production, showcasing adaptability. Today, they're laser-focused on biodefense while expanding CDMO capabilities. It's about being ready so tomorrow stays safe—no room for second chances in this arena.

**Areas of Work:** Biotechnology, Biodefense, Vaccine Manufacturing, Medical Countermeasures

## Things to Remember
- **Website:** https://ebsi.com
- **Address:** Gaithersburg, Maryland, United States
- **Contact:** 
- **Phone:** 
- **Hours:** 
- **Timezone:** 

The latest technical audit of ebsi.com scored 0 out of 100 overall. The audit makes 8 recommendations in all.

Emergent BioSolutions's company profile names Moderna, Pfizer, Johnson & Johnson and AstraZeneca as competitors. Its own llms.txt adds GSK and Sanofi. Outside its market, the domains ranked closest to it in our worldwide ranking are horizonstelecom.com, vyshka24.ru, lawfox.nl and lightwell.io.